No Data
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
The Accumulus Platform Powers Sanofi's Submissions to Multiple Regulators Around the World
Regeneron, Sanofi Announce EC Approval for Dupixent
Sanofi, Regeneron Receive European Pediatric Approval for Throat Disease Treatment
Express News | Regeneron And Sanofi's Dupixent Receives EU Approval For Children With Eosinophilic Esophagitis, Offering New Hope For Ages 1 To 11
Press Release: Dupixent Approved in the EU as the First and Only Medicine for Young Children With Eosinophilic Esophagitis
No Data
No Data
